Replacement medication for cocaine dependence: Methylphenidate

Journal of Clinical Psychopharmacology

Volumn 17, Issue 6, 1997, Pages 485-488

  Grabowski, John ^a   Roache, John D ^a   Schmitz, Joy M ^a   Rhoades, Howard ^a   Creson, Daniel ^a   Korszun, Ania ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; METHYLPHENIDATE; PLACEBO;

ADULT; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; DRUG URINE LEVEL; ELECTROCARDIOGRAM; FEMALE; HUMAN; MALE; NERVOUSNESS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SUSTAINED RELEASE PREPARATION;

ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE-RELATED DISORDERS; FEMALE; HUMANS; MALE; METHYLPHENIDATE;

EID: 0031402949     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199712000-00008     Document Type: Article

References (26)

1. Gawin FH, Kleber HD. Cocaine abuse treatment-open pilot trial with desipramine and lithium carbonate. Arch Gen Psychiatry 1984;41:903-9.
2. Kosten TR, Rounsaville BJ, Heber HD. A 2.5-year follow-up of cocaine use among treated opioid addicts: have our treatments helped? Arch Gen Psychiatry 1987;4:281-4.
3. Gawin FH, Kleber HD, Byck R, Rounsaville BJ, Kosten TR, Jatlow PI, Morgan C. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 1989;46:117-21.
4. Arndt IO, Dorozynsky L, Woody E, McLellan AT, O'Brien CP. Desipramine treatment of cocaine dependence in methadone maintained patients. Arch Gen Psychiatry 1992;49:888-93.
5. Kuhn KL, Halikas JA, Kemp KD. Carbamazepine treatment of cocaine dependence in methadone maintenance patients with dual opiate cocaine addiction. Proceedings of the College on Problems of Drug Dependence. NIDA Research Monograph No. 95. Washington, DC: DHHS, 1990:316-7.
6. Halikas JA, Crosby RD, Graves N. Double-blind carbamazepine enhancement in the treatment of cocaine abuse [abstract]. Annual Meeting of the American College of Neuropsychopharmacology, 1992:231.
7. Hatsukami D, Keenan R, Halikas JA, Pentel PR, Brauer LH. Effects of carbamazepine on acute responses to smoked cocaine-base in human cocaine users. Psychopharmacology (Berl) 1991;104:120-4.
8. Batki SL, Manfredi LB, Jacob P, Jones RT. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. J Clin Psychopharmacol 1993;13:243-50.
9. Batki SL, Washburn A, Manfredi LB, Murphy J, Herbst M, Jones TA, Nanda N, Jacob P, Jones RT. Fluoxetine in primary and secondary cocaine dependence: outcome measured by quantitative benzoylecgonine concentration. NIDA Research Monograph Series 141. NIH Publication No. 94-3749, 1994:140.
10. Grabowski J, Rhoades H, Elk R, Schmitz JM, Davis C, Creson D, Kirby K. Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: Two placebo-controlled, double-blind trials. J Clin Psychopharmacol 1995;15:163-74.
11. Ehrman RN, Robbins SJ, Cornish JW, Childress AR, O'Brien GP. Failure of ritanserin to block cocaine cue reactivity in humans. Drug Alcohol Depend 1997 (in press).
12. Greenhill LL, Osman BB. Ritalin: theory and patient management. New York: Liebert, Inc., 1991.
13. Bruera D, Renneis C, Paterson AHG, MacDonald RN. Narcotics plus methylphenidate (Ritalin) for advanced cancer pain. Am J Nurs 1988;11:1555-6.
14. Klein RG. The role of methylphenidate in psychiatry. Arch Gen Psychiatry 1995;52:429-33.
15. Spencer TS, Wilens T, Biederman J, Faraone SV, Ablon S, Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1995;52:434-43.
16. Khantzian EJ. An extreme case of cocaine dependence and marked improvement with methylphenidate treatment. Am J Psychiatry 1983;140:784-5.
17. Khantzian EJ, Gawin FH, Riordan C, Kleber HD. Methylphenidate treatment of cocaine dependence: a preliminary report. J Subst Abuse Treat 1984;1:107-12.
18. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985;142:1259-64.
19. Gawin FH, Riordan C, Kleber H. Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report. Am J Drug Alcohol Abuse 1985;11:193-7.
20. Levin F, Kleber H. Attention-deficit hyperactivity disorder and substance abuse: relationships and implications for treatment. Harv Rev Psychiatry 1995;2:246-55.
21. Chait LD. Reinforcing and subjective effects of methylphenidate in humans. Behav Pharmacol 1994;5:281-8.
22. Grabowski J, Roache JD, Thomson W, Schmitz JM. Methylphenidate: adjunct in cocaine treatment? Annual Meeting of the College on Problems of Drug Dependence. Scottsdale, AZ, June 1995.
23. Roache JD, Thomson W, Schmitz J, Grabowski J. Methylphenidate effects in cocaine dependent patients: laboratory assessment and treatment outcome. Proceedings of the 56th Annual Meeting of the College on Drug Dependence, NIDA Research Monograph No. 153. Washington, DC, 1995:218.
24. Dixon WJ, Merdian KL. ANOVA and regression with BMDP 5V. Los Angeles: Dixon Statistical Associates, 1992.
25. Volkow ND, Ding Y-S, Fowler JS, Wang G-J, Logan J, Gatley JS, Dewey S, Ashby C, Liebermann J, Hitzemann R, Wolf AP. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 1995;52: 456-63.
26. Glowa JR, Fantegrossi WE, Lewis DB, Matecka D, Kenner CR, Rothman RB. Sustained decrease in cocaine-maintained responding in Rhesus monkeys with a long-acting GBR 12909 decanoate ester derivative. J Med Chem 1996;39:4689-91.